TNKS2 Protein

TNKS2 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TNKS2 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Tankyrase 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TNKS2</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H2K2</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>PARP5B, TANK2, TNKS-2</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~139 kDa</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1206 amino acids</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10q23.33</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus, cytoplasm, plasma membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>PARP family (PARP5)</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">XAV939</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">IWR-1</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">WIKI4</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">NVP-TNKS656</td>
<td>TNKS1-selective</td>
</tr>
<tr>
<td class="label">G007-LK</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">Isoelectric point</td>
<td>7.8</td>
</tr>
<tr>
<td class="label">Oligomeric state</td>
<td>Homooligomer</td>
</tr>
<tr>
<td class="label">PAR c

TNKS2 Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TNKS2 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Tankyrase 2</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TNKS2</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H2K2</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>PARP5B, TANK2, TNKS-2</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~139 kDa</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1206 amino acids</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10q23.33</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus, cytoplasm, plasma membrane</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>PARP family (PARP5)</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">XAV939</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">IWR-1</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">WIKI4</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">NVP-TNKS656</td>
<td>TNKS1-selective</td>
</tr>
<tr>
<td class="label">G007-LK</td>
<td>Dual TNKS1/2</td>
</tr>
<tr>
<td class="label">Isoelectric point</td>
<td>7.8</td>
</tr>
<tr>
<td class="label">Oligomeric state</td>
<td>Homooligomer</td>
</tr>
<tr>
<td class="label">PAR chain length</td>
<td>Up to 20 units</td>
</tr>
<tr>
<td class="label">Kd for NAD+</td>
<td>~40 μM</td>
</tr>
<tr>
<td class="label">Substrate specificity</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous, high in brain</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Tankyrase 2 (TNKS2), also known as PARP5B, is a 1206 amino acid protein belonging to the poly(ADP-ribose) polymerase (PARP) family. TNKS2 shares significant homology with its paralog TNKS1 (Tankyrase 1) and performs both overlapping and distinct cellular functions[@smith2022]. As a member of the PARP family, TNKS2 synthesizes poly(ADP-ribose) (PAR) chains onto target proteins, a post-translational modification that regulates protein-protein interactions, stability, and cellular localization[@guettler2021].

TNKS2 has emerged as an important player in neurodegeneration research due to its roles in Wnt signaling, telomere maintenance, protein quality control, and metabolic regulation. Dysregulation of TNKS2 has been implicated in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative conditions[@yang2018][@zhao2023]. The protein's enzymatic activity and scaffolding functions make it a potential therapeutic target for developing disease-modifying treatments.

Protein Information

Structure and Domains

TNKS2 possesses a multi-domain architecture that enables its diverse cellular functions:

N-Terminal Region

The N-terminal region of TNKS2 contains multiple protein interaction domains:

• Ankyrin Repeat Clusters (ANK): Six ankyrin repeats organized in two clusters (ANC1 and ANC2), each containing three repeats. These domains mediate protein-protein interactions with substrate proteins and determine PARylation specificity[@guettler2021]. The ankyrin repeats form a characteristic fold that creates a hydrophobic binding pocket for recognizing specific sequence motifs in substrates.
• Sterile Alpha Motif (SAM): Five SAM domains located N-terminal to the catalytic domain. These domains facilitate protein oligomerization and are required for proper TNKS2 function in signaling pathways[@sbodio2020]. The SAM domains can form polymers that may serve as scaffolds for signaling complexes.

Catalytic PARP Domain

The C-terminal region contains the catalytic PARP domain responsible for enzymatic activity:

• Catalytic Core: Synthesizes poly(ADP-ribose) chains using NAD+ as substrate
• Auto-modification Site: TNKS2 can PARylate itself, regulating its own activity and protein interactions
• Warner vs. HPS domain: The helical domain contributes to substrate specificity

Substrate Recognition

TNKS2 recognizes specific sequence motifs in substrates, primarily through the ankyrin repeat clusters. The RGSXXP motif found in proteins like Axin and BLZF1 is a well-characterized TNKS2 binding site[@sbodio2020]. This recognition is shared with TNKS1, explaining functional overlap, but unique substrates may explain distinct cellular roles.

Normal Cellular Functions

Wnt/β-Catenin Signaling Regulation

TNKS2 plays a key role in modulating canonical Wnt/β-catenin signaling through PARylation of key pathway components[@sbodio2020]:

Axin PARylation and Degradation:

• TNKS2 PARylates Axin, a critical component of the β-catenin destruction complex
• PARylated Axin is recognized by the E3 ubiquitin ligase RNF146
• Ubiquitination targets Axin for proteasomal degradation
• Reduced Axin levels decrease β-catenin phosphorylation and degradation
• Stabilized β-catenin translocates to the nucleus and activates Wnt target genes

• TNKS1 and TNKS2 both PARylate Axin
• TNKS2 can partially compensate for TNKS1 loss
• Complete signaling inhibition requires dual inhibition
• The redundancy has implications for therapeutic targeting

• Wnt signaling dysregulation contributes to neurodegeneration
• Both hyperactive and hypoactive Wnt have been implicated in AD and PD
• TNKS2 modulation must consider this delicate balance

Telomere Biology

TNKS2 participates in telomere maintenance through interactions with telomeric proteins[@nagy2019]:

• Telomere Recruitment: TNKS2 can localize to telomeres through interaction with shelterin complex proteins
• Length Regulation: TNKS2 contributes to telomere length control
• Compensation Function: TNKS2 can partially compensate for TNKS1 deficiency at telomeres
• Alternative Functions: May have telomere-independent roles in genomic stability

Protein Quality Control

Emerging evidence suggests TNKS2 participates in protein quality control pathways[@liu2023]:

• Aggregation Regulation: TNKS2-mediated PARylation can influence protein aggregate formation
• Proteasomal Targeting: PAR chains can serve as degradation signals
• Autophagy Modulation: TNKS2 activity affects autophagic flux
• Stress Response: TNKS2 expression changes under cellular stress conditions

Metabolic Functions

TNKS2 influences cellular metabolism:

• NAD+ Consumption: As a PARP, TNKS2 consumes NAD+ during poly(ADP-ribosyl)ation
• Energy Metabolism: PARylation can affect metabolic enzyme activity
• Mitochondrial Function: TNKS2 may regulate mitochondrial protein quality

Role in Neurodegenerative Diseases

Alzheimer's Disease

TNKS2 is implicated in multiple aspects of AD pathogenesis[@chen2024][@yang2024]:

Amyloid-beta Processing:

• TNKS2 activity affects APP processing and Aβ production
• Wnt signaling modulation influences γ-secretase activity
• PARylation of BACE1 may regulate Aβ generation

• TNKS2-mediated signaling affects tau phosphorylation through GSK3β modulation
• Tankyrase inhibition reduces tau pathology in cellular models
• Tau itself may regulate TNKS2 activity

• Wnt signaling is essential for synaptic plasticity
• TNKS2 dysregulation contributes to synaptic deficits
• Axonal transport impairment involves TNKS2

• TNKS2 inhibitors show neuroprotective effects in AD models
• Combination approaches targeting multiple pathways may be beneficial
• BBB penetration is a key consideration for therapeutic development

Parkinson's Disease

TNKS2 contributes to PD pathogenesis through several mechanisms[@park2024][@wu2023]:

α-Synuclein Metabolism:

• TNKS2 affects autophagy and protein clearance pathways
• PARylation can influence α-synuclein aggregation
• Tankyrase inhibition reduces α-synuclein toxicity

• TNKS2 regulates mitochondrial protein quality
• PARP activation depletes NAD+ and affects mitochondrial health
• Tankyrase inhibition preserves mitochondrial function

• TNKS2 modulates inflammatory signaling
• PARylation affects microglial activation states
• Tankyrase inhibitors reduce neuroinflammation in models

• Wnt signaling promotes dopaminergic neuron survival
• TNKS2 modulation affects neuron viability
• Therapeutic targeting may protect vulnerable neurons

Other Neurodegenerative Conditions

TNKS2 involvement has been suggested in:

• Huntington's Disease: Protein quality control mechanisms
• Amyotrophic Lateral Sclerosis: Stress response pathways
• Frontotemporal Dementia: Similar to ALS mechanisms

Therapeutic Targeting

Tankyrase Inhibitors

Several classes of tankyrase inhibitors have been developed[@wang2022][@eisemann2021]:

Therapeutic Strategies

Direct Inhibition:

• Small molecule inhibitors block catalytic activity
• Challenges include achieving brain penetration
• Selective vs. dual inhibition considerations

• Tankyrase inhibitors with Wnt modulators
• Synergy with proteostasis enhancers
• Anti-inflammatory combination strategies

Challenges and Considerations

Biochemical Properties

Cross-Linking Relationships

Related Proteins

• [TNKS1 (Tankyrase 1)](/proteins/tnks-protein) — Paralog with overlapping functions
• [Axin](/proteins/axin-protein) — Key substrate in Wnt signaling
• [β-Catenin](/proteins/beta-catenin-protein) — Wnt pathway effector
• [GSK3β](/proteins/gsk3-beta-protein) — Kinase regulating tau phosphorylation

Related Pathways

• [Wnt Signaling Pathway](/mechanisms/wnt-signaling) — Major TNKS2-regulated pathway
• [PARP Signaling](/mechanisms/parp-pathway) — Enzymatic function
• [Protein Quality Control](/mechanisms/protein-quality-control-network) — Emerging role
• [Telomere Biology](/entities/telomere-biology) — Maintenance function

Disease Associations

• [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease link
• [Parkinson's Disease](/diseases/parkinsons-disease) — Significant implication
• [Cancer](/entities/cancer) — Overexpression in multiple malignancies

See Also

• [TNKS2 Gene](/genes/tnks2)
• [TNKS1 Protein](/proteins/tnks-protein)
• [Wnt Signaling Pathway](/mechanisms/wnt-signaling)
• [PARP Proteins](/entities/parp-proteins)
• [Alzheimer's Disease Mechanisms](/mechanisms/alzheimers-pathogenesis)
• [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-pathogenesis)

External Links

• [UniProt: Q9H2K2](https://www.uniprot.org/uniprot/Q9H2K2)
• [NCBI Gene: TNKS2](https://www.ncbi.nlm.nih.gov/gene/80314)
• [PDB: TNKS2 Structure](https://www.rcsb.org/structure/3T0I)
• [IUPHAR: Tankyrases](https://www.guidetopharmacology.org/GRAC/familyDisplayForward?familyId=837)

Research Directions

Current Questions

Emerging Research Areas

• [Selective inhibitor development: Achieving brain-penetrant, selective compounds](/home)
• Biomarker development: Identifying TNKS2 activity markers
• Combination therapies: Rational combinations with other approaches
• Genetic models: Understanding tissue-specific functions

References